US government has finalized a financing arrangement with Hyderabad-based Biological E Limited formalizing 50 million Dollars to expand the company's capacity to produce COVID-19 vaccines.<br />''<br />''In a statement, the US embassy in India said, the continued partnership will help bolster near-term COVID-19 response efforts and will also benefit long-term global health in India and throughout the Indo-Pacific region.<br />''<br />''The development underscores the significance of the agreement under the Quad Vaccine Partnership.<br />''<br />''<br />''<br />